Moreover, postoperative serum B2M levels were lower than preoperative levels in the majority of glioma patients.<h4>Conclusions</h4>High preoperative serum B2M levels correlated with malignant glioma and a poor prognosis. Here, B2M is linked to central nervous system cancer.